87 online
 
Most Popular Choices
Share on Facebook 23 Printer Friendly Page More Sharing Summarizing
General News   

Inside the opioid sales machine of Mallinckrodt Pharmaceuticals

Quicklink Submitted By   1 comment

Susan Lee Schwartz
Follow Me on Twitter     Message Susan Lee Schwartz
Become a Fan
  (23 fans)

The largest manufacturer of opioids in the United States once cultivated a reliable stable of hundreds of doctors it could count on to write a steady stream of prescriptions for pain pills. More than a quarter of top prescribers ranked by Mallinckrodt Pharmaceuticals during the height of the pain pill epidemic, in 2013, were later convicted of crimes related to their medical practices, had their medical licenses suspended or revoked, or paid state and federal fines after being accused of wrongdoing. The documents, made public after years of litigation and bankruptcy proceedings, shed new light on how aggressively Mallinckrodt sought to increase its market share as the epidemic was raging.

Read the rest of the story HERE:

At www.washingtonpost.com
Rate It | View Ratings

Susan Lee Schwartz Social Media Pages: Facebook Page       Twitter Page       Linked In Page       Instagram Page

I began teaching in 1963,; Ba and BS in Education -Brooklyn College. I have the equivalent of 2 additional Master's, mainly in Literacy Studies and Graphic Design. I was the only seventh grade teacher of English from 1990 -1999 at East Side (more...)
 

Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Follow Me on Twitter     Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation:

Tell A Friend